Related Experiment Videos
Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties
1Center de Recherche, Hôpital Sainte-Justine, Université de Montréal Montréal, Québec, Canada.
Journal of Thrombosis and Haemostasis : JTH
|May 5, 2005
Summary
Factor VIIa (FVIIa) promotes cell proliferation through tissue factor (TF) and protease-activated receptor-2 (PAR-2), distinct from thrombin
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Factor VIIa (FVIIa) possesses cell proliferative properties beyond hemostasis, implicated in angiogenesis and tumor growth.
- The roles of tissue factor (TF) and protease-activated receptors (PARs) in FVIIa-mediated cell proliferation require clarification.
Purpose of the Study:
- To investigate the hypothesis that FVIIa induces cell proliferation via a mechanism involving TF and PAR-2.
Main Methods:
- Utilized human recombinant FVIIa on BOSC23 cells expressing human TF.
- Employed a reporter gene assay with the DNA primase 1 (PRIM1) promoter linked to chloramphenicol acetyl transferase (CAT).
- Assessed the effects of TF antisense oligonucleotides, PAR-1, and PAR-2 antagonists, intracellular calcium, and p44/42 MAP kinase phosphorylation.
Main Results:
- FVIIa dose-dependently increased cell proliferation and PRIM1 induction, potentiated by TF and abrogated by TF antisense.
- PRIM1 induction by FVIIa was abolished by PAR-2 but not PAR-1 antagonists.
- FVIIa's proliferative effects involved TF-dependent intracellular calcium increase and p44/42 MAP kinase phosphorylation.
Conclusions:
- FVIIa induces PRIM1 and cell proliferation through a TF- and PAR-2-dependent pathway.
- Thrombin's proliferative effects are PAR-1-dependent and TF-independent.
- Inhibitors targeting the FVIIa-TF-PAR-2 pathway may suppress cell proliferation.